CRL vs NKSH · rev $2.00B vs P/E 21, rev $4.4M
Charles River Laboratories (CRL) versus National Bankshares Inc (NKSH) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
National Bankshares Inc (NKSH) is a banks - regional company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported NKSH revenue for 2026-06-30 was $4.4M. Net income was $10.0M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. NKSH currently screens at market cap $187.2M and trailing P/E 21.3.
CRL currently screens at market cap $7.78B. NKSH currently screens at market cap $187.2M and trailing P/E 21.3.
Not investment advice. Open the CRL and NKSH stock pages for the full models.
Not investment advice.